Episodes

4 hours ago
4 hours ago
Join rheumatology experts Dr. John J. Cush and Dr. Arthur Kavanaugh for the EULAR Rheumatology RoundUp — a dynamic, fast-paced discussion capturing the most impactful highlights, late-breaking data, and clinical takeaways from EULAR 2025.

2 days ago
EULAR 2025 - Day 9 podcast
2 days ago
2 days ago
Trends and Innovations from Barcelona (6.20.2025)
AI Advances axSpA Diagnosis with Multimodal MRI
IL-17 Inhibitors in Psoriatic Arthritis
IL-17 Inhibitors for Axial Spondyloarthritis
New IL-17 Inhibition New Molecular Constructs

6 days ago

6 days ago
EULAR 2025 - Day 8 podcast
6 days ago
6 days ago
Resilience or Resignation? Rethinking Pain, Aging, and Quality of Life
Spondyloarthritis Panel: Eular 2025

7 days ago
EULAR 2025 – SpA Panel Discussion
7 days ago
7 days ago
Leading rheumatology experts discuss the latest research, treatment advances, and clinical insights in axial spondyloarthritis. Hear what’s new from EULAR 2025 and what it means for improving patient outcomes.

7 days ago
EULAR 2025 - Day 7 podcast
7 days ago
7 days ago
Digital Behavioural Therapy for Persistent Pain in Axial Spondyloarthritis
There's an App for That (and it works): the AXIA RCT

Tuesday Jun 17, 2025
EULAR 2025 - Day 6 podcast
Tuesday Jun 17, 2025
Tuesday Jun 17, 2025
Eular 2025 PsA Topic Panel
Assessment of Peripheral Arthritis in Spondyloarthritis
IL-17 inhibitors - Novel Drugs
IL17 inhibitors - Long-term Extensions and Uveitis
IL17 inhibitors - STAMP T2T and Combinations
Using AI for Reading PET/CT in Rheumatoid Arthritis

Tuesday Jun 17, 2025

Monday Jun 16, 2025
EULAR 2025 – RA Panel Discussion
Monday Jun 16, 2025
Monday Jun 16, 2025
Leading experts in rheumatology dive into the latest advances, treatment strategies, and emerging research in rheumatoid arthritis. Don’t miss this in-depth panel as they unpack key findings from EULAR 2025 and discuss what’s next for RA care.

Monday Jun 16, 2025
EULAR2025 Topic Podcast IL-17
Monday Jun 16, 2025
Monday Jun 16, 2025
Efficacy and Safety of Xeligekimab in AS
Sonelokimab in PsA
Seronegative Arthritis Breakthroughs
Novel Therapies in Axial Spondyloarthritis